Seelos Therapeutics Inc (NASDAQ: SEEL): Do Not Miss The Gain Train

Seelos Therapeutics Inc (SEEL) concluded trading on Thursday at a closing price of $0.59, with 0.44 million shares of worth about $0.26 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -90.25% during that period and on March 28, 2024 the price saw a loss of about -7.56%. Currently the company’s common shares owned by public are about 13.68M shares, out of which, 12.49M shares are available for trading.

However, the stock later moved at a day high price of 0.6800, or with a loss of -7.56%. Stock saw a price change of 20.59% in past 5 days and over the past one month there was a price change of -49.05%. Year-to-date (YTD), SEEL shares are showing a performance of -57.48% which decreased to -97.19% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.37 but also hit the highest price of $49.80 during that period. The average intraday trading volume for Seelos Therapeutics Inc shares is 436.27K. The stock is currently trading -35.97% below its 20-day simple moving average (SMA20), while that difference is down -38.01% for SMA50 and it goes to -95.90% lower than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Seelos Therapeutics Inc (NASDAQ: SEEL) currently have 13.68M outstanding shares and institutions hold larger chunk of about 13.05% of that.

The stock has a current market capitalization of $8.08M and its 3Y-monthly beta is at 1.89. It has posted earnings per share of -$8.72 in the same period. It has Quick Ratio of 0.14. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SEEL, volatility over the week remained 15.37% while standing at 17.40% over the month.

Analysts are in expectations that Seelos Therapeutics Inc (SEEL) stock would likely to be making an EPS of -$1.48 in the current quarter, while forecast for next quarter EPS is -$1.19 and it is $0 for next year. For the current quarter EPS, analysts have given the company a lowest target -$1.48 which is -$1.48 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$3.6 in the same quarter a year ago.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by ROTH Capital on September 27, 2021 offering a Buy rating for the stock and assigned a target price range of between $2.50 and $8 to it. Coverage by Guggenheim stated Seelos Therapeutics Inc (SEEL) stock as a Buy in their note to investors on July 01, 2021, suggesting a price target of $8 for the stock. Stock get a Buy rating from B. Riley Securities on March 30, 2021.

Most Popular

Related Posts